ARCHIVES

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

Breast Cancer Activist, Radiologist Are Added To Special Commission

November 6, 1992

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

Trials Approved by NCI CTEP For the Month of December

December 30, 2011

Mammography Quality Standards Set, FDA User Fees Enacted; Oral Cancer Drugs Covered

October 16, 1992

EORTC Screening, Pharmacology Group Focuses On CNU

January 2, 1987